We will host our What the AI Act means for Medical Devices webinar on Thursday 30 May from 4.00pm - 5.00pm (Irish Time).
During this webinar, we will consider the impact of the AI Act on the medical device industry. Through Q&A with experts from industry, legal and notified body TÜV SÜD, we will consider what the AI Act means for medical device manufacturers, what changes will be coming into effect and what manufacturers should be doing now to prepare.
Our expert speakers will consider these issues through the lens of legal, regulatory and notified body requirements. We will specifically consider:
- The gap between current compliance for AI medical devices and when the AI Act applies
- What real world challenges manufacturers will face in addressing that gap
- How the new combined conformity assessment procedure will look, and
- What all of this means in practical terms with a focus on data and documentation requirements
Panellists include:
- Brian McElligott, Partner & Head of Artificial Intelligence (AI) Mason Hayes & Curran
- Marco Caproni, Senior Product Specialist Software, TÜV SÜD
- Shweta Agarwal, Director and Senior Regulatory Consultant, Cqura Ltd
This event will be chaired by Michaela Herron, Partner and Head of Life Sciences, Mason Hayes & Curran.
To * register for this webinar, please complete the below form.
